Conclusion
itching, AD
DISEASE, RECRUITMENT
The study interventions were feasible and acceptable for patients with mild-to-moderate severe AD, however, the recruitment was difficult due to the COVID-19 pandemic. Despite very small groups, study results indicated potential beneficial changes to baseline in perceived itching intensity, disease severity, and disease-specific QoL for HTP and IFDP. Therefore, further high-quality clinical trials should be performed investigating the effectiveness and safety of hypnotherapy, fasting with diet adjustments, as well as exercise.